Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease

Chia Jung Hsieh, Hsin Chu, Joseph Jror Serk Cheng, Winston W. Shen, Chia Chin Lin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aim: Apathy is a well-recognized symptom of Alzheimer's disease (AD). The aim of the present study was to validate the Taiwanese version of the Apathy Evaluation Scale, clinician version (AES-C) and assess the severity of apathy in patients with AD. Methods: Comprehensive evaluations were conducted in a total of 144 AD patients. This study used a cross-sectional comparative design. Data were collected from clinical interviews using the AES, the Mini-Mental Status Examination (MMSE), the Neuropsychiatric Inventory (NPI), and the Clinical Dementia Rating Scale (CDR). Results: Internal consistency was indicated by Cronbach's alphas of 0.85; test-retest reliability was 0.89 over a period of 3 days. Criterion-related validity was supported by the fact that AES-C significantly correlated with the apathy scores of the NPI. Factor analysis indicated a three-factor structure. Convergent validity was supported by a positive correlation between the AES-C score and the anxiety score of the NPI. Discriminant validity was supported by the fact that the AES-C scores did not correlate with the depression subscale of the NPI, and the correlation between the AES-C score and the euphoria score of the NPI score was negative. Known-group validity was supported by results showing that AD patients in a moderate stage of dementia (CDR = 2) had significantly higher scores on the AES-C than patients with mild-stage dementia (CDR = 1). Conclusion: The AES-C is a reliable and valid instrument for measuring symptoms of apathy among AD patients in Taiwan.

Original languageEnglish
Pages (from-to)227-234
Number of pages8
JournalPsychiatry and Clinical Neurosciences
Volume66
Issue number3
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Apathy
Alzheimer Disease
Dementia
Equipment and Supplies
Taiwan
Reproducibility of Results
Statistical Factor Analysis
Anxiety

Keywords

  • apathy
  • apathy evaluation scale
  • family distress
  • reliability
  • validation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease. / Hsieh, Chia Jung; Chu, Hsin; Cheng, Joseph Jror Serk; Shen, Winston W.; Lin, Chia Chin.

In: Psychiatry and Clinical Neurosciences, Vol. 66, No. 3, 04.2012, p. 227-234.

Research output: Contribution to journalArticle

@article{4a89e6e029294501b38218386d654b6e,
title = "Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease",
abstract = "Aim: Apathy is a well-recognized symptom of Alzheimer's disease (AD). The aim of the present study was to validate the Taiwanese version of the Apathy Evaluation Scale, clinician version (AES-C) and assess the severity of apathy in patients with AD. Methods: Comprehensive evaluations were conducted in a total of 144 AD patients. This study used a cross-sectional comparative design. Data were collected from clinical interviews using the AES, the Mini-Mental Status Examination (MMSE), the Neuropsychiatric Inventory (NPI), and the Clinical Dementia Rating Scale (CDR). Results: Internal consistency was indicated by Cronbach's alphas of 0.85; test-retest reliability was 0.89 over a period of 3 days. Criterion-related validity was supported by the fact that AES-C significantly correlated with the apathy scores of the NPI. Factor analysis indicated a three-factor structure. Convergent validity was supported by a positive correlation between the AES-C score and the anxiety score of the NPI. Discriminant validity was supported by the fact that the AES-C scores did not correlate with the depression subscale of the NPI, and the correlation between the AES-C score and the euphoria score of the NPI score was negative. Known-group validity was supported by results showing that AD patients in a moderate stage of dementia (CDR = 2) had significantly higher scores on the AES-C than patients with mild-stage dementia (CDR = 1). Conclusion: The AES-C is a reliable and valid instrument for measuring symptoms of apathy among AD patients in Taiwan.",
keywords = "apathy, apathy evaluation scale, family distress, reliability, validation",
author = "Hsieh, {Chia Jung} and Hsin Chu and Cheng, {Joseph Jror Serk} and Shen, {Winston W.} and Lin, {Chia Chin}",
year = "2012",
month = "4",
doi = "10.1111/j.1440-1819.2011.02315.x",
language = "English",
volume = "66",
pages = "227--234",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease

AU - Hsieh, Chia Jung

AU - Chu, Hsin

AU - Cheng, Joseph Jror Serk

AU - Shen, Winston W.

AU - Lin, Chia Chin

PY - 2012/4

Y1 - 2012/4

N2 - Aim: Apathy is a well-recognized symptom of Alzheimer's disease (AD). The aim of the present study was to validate the Taiwanese version of the Apathy Evaluation Scale, clinician version (AES-C) and assess the severity of apathy in patients with AD. Methods: Comprehensive evaluations were conducted in a total of 144 AD patients. This study used a cross-sectional comparative design. Data were collected from clinical interviews using the AES, the Mini-Mental Status Examination (MMSE), the Neuropsychiatric Inventory (NPI), and the Clinical Dementia Rating Scale (CDR). Results: Internal consistency was indicated by Cronbach's alphas of 0.85; test-retest reliability was 0.89 over a period of 3 days. Criterion-related validity was supported by the fact that AES-C significantly correlated with the apathy scores of the NPI. Factor analysis indicated a three-factor structure. Convergent validity was supported by a positive correlation between the AES-C score and the anxiety score of the NPI. Discriminant validity was supported by the fact that the AES-C scores did not correlate with the depression subscale of the NPI, and the correlation between the AES-C score and the euphoria score of the NPI score was negative. Known-group validity was supported by results showing that AD patients in a moderate stage of dementia (CDR = 2) had significantly higher scores on the AES-C than patients with mild-stage dementia (CDR = 1). Conclusion: The AES-C is a reliable and valid instrument for measuring symptoms of apathy among AD patients in Taiwan.

AB - Aim: Apathy is a well-recognized symptom of Alzheimer's disease (AD). The aim of the present study was to validate the Taiwanese version of the Apathy Evaluation Scale, clinician version (AES-C) and assess the severity of apathy in patients with AD. Methods: Comprehensive evaluations were conducted in a total of 144 AD patients. This study used a cross-sectional comparative design. Data were collected from clinical interviews using the AES, the Mini-Mental Status Examination (MMSE), the Neuropsychiatric Inventory (NPI), and the Clinical Dementia Rating Scale (CDR). Results: Internal consistency was indicated by Cronbach's alphas of 0.85; test-retest reliability was 0.89 over a period of 3 days. Criterion-related validity was supported by the fact that AES-C significantly correlated with the apathy scores of the NPI. Factor analysis indicated a three-factor structure. Convergent validity was supported by a positive correlation between the AES-C score and the anxiety score of the NPI. Discriminant validity was supported by the fact that the AES-C scores did not correlate with the depression subscale of the NPI, and the correlation between the AES-C score and the euphoria score of the NPI score was negative. Known-group validity was supported by results showing that AD patients in a moderate stage of dementia (CDR = 2) had significantly higher scores on the AES-C than patients with mild-stage dementia (CDR = 1). Conclusion: The AES-C is a reliable and valid instrument for measuring symptoms of apathy among AD patients in Taiwan.

KW - apathy

KW - apathy evaluation scale

KW - family distress

KW - reliability

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=84859049962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859049962&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1819.2011.02315.x

DO - 10.1111/j.1440-1819.2011.02315.x

M3 - Article

C2 - 22443245

AN - SCOPUS:84859049962

VL - 66

SP - 227

EP - 234

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 3

ER -